Corrigendum to "Performance of the Abbott RealTime™ HIV-1 assay for quantification of HIV-1 clades prevalent in China" [J. Clin. Virol. 41 (2008) 305-309] (DOI:10.1016/j.jcv.2008.01.009);Performance of the Abbott RealTime™ HIV-1 assay for quantification of HIV-1 clades prevalent in China

Journal of Clinical Virology

Volumn 41, Issue 4, 2008, Pages 305-309

  Xu, Sihong ^a   Song, Aijing ^a   Li, Xiuhua ^a   Li, Jingyun ^b   Bao, Zuoyi ^b   Mao, Panyong ^c   Zhao, Qing ^c   Wang, Youchun ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c BEIJING 302 HOSPITAL   (China)

Author keywords

Abbott RealTime ; HIV 1; NucliSens EasyQ ; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ARTICLE; ASSAY; BLOOD DONOR; CHINA; CLADISTICS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 40849140483     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.04.012     Document Type: Erratum

References (11)

1. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
2. de Mendoza C., Koppelman M., Montes B., Ferre V., Soriano V., Cuypers H., et al. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Methods 127 (2005) 54-59
3. Deiman B., Aarle P., and Sillekens P. Characteristics and applications of nucleic acid sequence based amplification (NASBA). Mol Biotechnol 20 (2002) 163-179
4. Garcia-Diaz A., Clewley G.S., Booth C.L., Labett W., McAllister N., and Geretti A.M. Comparative evaluation of the performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J Clin Microbiol 44 (2006) 1788-1791
5. Stevens W., Wiggill T., Horsfield P., Coetzee L., and Scott L.E. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. J Virol Methods 124 (2005) 105-110
6. Swanson P., de Mendoza C., Joshi Y., Golden A., Hodinka R.L., Soriano V., et al. Impact of Human Immunodeficiency Virus Type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 43 (2005) 3860-3868
7. Swanson P., Huang S., Holzmayer V., Bodelle P., Yamaguchi J., Brennan C., et al. Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Methods 134 (2006) 237-243
8. ® HIV RNA quantitative assays. J Virol Methods 137 (2006) 184-192
9. Swanson P., Huang S., Abravaya K., de Mendoza C., Soriano V., Devare S.G., et al. Evaluation of performance across the dynamic range of the Abbott RealTime™ HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. J Virol Methods 141 (2007) 49-57
10. Wang Y., Song A., Xu S., Li X., Chong H., Zhao C., et al. The impact of HIV-1 genetic diversity in China on the measurement of viral load. J Med Virol 80 (2008) 1-8
11. Yao J., Liu Z., Ko L.S., Pan G., and Jiang Y. Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Methods 129 (2005) 40-46